In 2021, the National Committee for Quality Assurance (NCQA), a nonprofit organization dedicated to improving health care quality through the publication of evidence-based standards and measures, released proposed changes to its colorectal cancer (CRC) screening measure. Recognizing that CRC is an important area for personalized medicine because molecularly guided testing strategies span the entire course of the disease, PMC submitted a brief comment letter emphasizing the importance of increased CRC screening to personalized medicine, supporting alignment of NCQA’s CRC screening measure with recently updated clinical guidelines, and highlighting the need for changes to data reporting methods that will improve collection and sharing across health systems.
The Personalized Medicine Report: Opportunity, Challenges, and the Future demonstrates that personalized medicine can make patients healthier while lowering systemic costs.
» The Personalized Medicine Report: Opportunity, Challenges, and the Future (PDF)
PMC members shape and advance the future of personalized medicine.